Background/Aim: Upper limb breast cancerrelated lymphedema (BCRL) is a chronic and severe condition affecting a significant percentage of breast cancer survivors. Even though its physiopathology is well-known, there is no worldwide consensus on BCRL evaluation and a goldstandard treatment. This narrative review aims at providing a brief descriptive overview with regard to BCRL treatment modalities. Materials and Methods: We conducted a literature search within the PubMed database, and 33 articles out of 56 were selected, including reviews, systematic reviews, and meta-analyses aiming find the most updated evidence regarding BCRL treatment modalities. Results: Physical exercise (aerobic exercise, resistance exercise, aquatic therapy), bandages, and intermittent pneumatic compression were shown to be most effective in BCRL patients, in terms of swelling reduction in the acute-intensive phase. Furthermore, physical exercise was beneficial also as a maintenance tool. Manual lymphatic drainage demonstrated efficacy in preventing secondary lymphedema if applied immediately after breast cancer surgery or in early phases of BCRL or as a maintenance tool. Complementary procedures such as acupuncture, reflexology, yoga and photo-biomodulation therapy did not show conclusive results in BCRL treatment. Surgery was shown effective in managing symptoms (liposuction), preventing (lymphaticovenular anastomosis) and treating BCRL (vascularized lymph node transfer). Conclusion: BCRL is still a challenging condition either for breast cancer survivors and clinicians, deeply impacting patient functioning and quality of life. Due to the lack of globally accepted criteria in evaluating BCRL, to date a gold standard treatment for this widespread issue is still needed.Improved survival rates in breast cancer patients contribute to an increased number of survivors complaining of upper limb Breast Cancer-Related Lymphedema (BCRL), which is a secondary lymphedema after surgery and radiation therapy (1). BCRL is a common complication occurring after lymph node dissection for breast or upper limb tumors (e.g., melanoma), and it is generally caused by an excessive accumulation of protein-rich fluid (lymph) in tissue extracellular spaces that causes transient or persistent soft tissue swelling (2). Up to 30% (3-5) of breast cancer survivors, may suffer from BCRL and its physical and psychological consequences such as: pain, pitting edema, upper limb heaviness and discomfort, decreased range of motion of the affected joints, recurrent skin infections and ulcers, elephantiasis, cutaneous angiosarcoma, depression, anxiety, body image-related disorder. Quality of life (QoL) is dramatically worsened by BCRL.